Search Results for: search.php

VeraChem LLC founders Drs. Michael Gilson, Michael Potter, and Hillary Gilson, using UMBI licensed intellectual property, are creating scientific software that provides expert users with tools for computer-aided drug discovery and molecular design. VeraChem’s recent first sale, a pre-release version of Vconf, is followed by the projected launch on September 8 of Vcharge, a new software product for computing molecular properties important in drug design. The official launch of Vconf is expected to f

Ever since Darwin’s day, scientists have been trying to understand how interactions among living creatures—competition and predation, for example—drive evolution.

Recent work by paleontologists Tomasz Baumiller of the University of Michigan and Forest Gahn of the Smithsonian’s National Museum of Natural History offers new insights into the process. A report on their research appears in today’s issue of Science.

Biologists long have speculated that preda

Ticks as small as a freckle can transmit a number of illnesses for which there is no vaccine and, in some cases, no cure. These creatures even could become bioterrorism weapons.

To find new ways to control the tiny animals and halt the spread of the pathogens they carry, Purdue University researchers and colleagues from the University of Connecticut Health Center, the University of Notre Dame and Massachusetts Institute of Technology are undertaking the job of unraveling the genetic

Space digest: September 2004

This release contains a summary of some significant astronomical and space events that will be taking place during September. It has been written in order to assist the media in planning and researching future stories related to space science and astronomy, particularly those with UK involvement. It is not intended to be fully comprehensive. Dates and times may be subject to change.

3 September: ISS Spacewalk

NASA Flight Engineer a

University of Chicago scientists have solved a 20-year-old puzzle in particle physics using data from an experiment conducted for an entirely different purpose.

Physicists had long known that something was amiss regarding their understanding of how some quarks interact in the beta decay of particles, a common form of radioactivity. Either dozens of experiments conducted over a period of more than three decades were wrong, or the scientists’ theories were. Now, in a set of four

Nature Immunology commentary highlights promising advances in the field Recent discoveries about the way that HIV infects cells are propelling the development of a broad spectrum of promising new antiviral drugs, according to an invited commentary on the topic in the current issue of Nature Immunology (August 27, 2004).

The assessment is made by Gladstone Institute of Virology and Immunology (GIVI) Director Warner Greene, MD, PhD, who also serves as professor of medicine, microbiol